Polat Olgun - Publications

Long-read sequencing bridges germline and somatic variant detection: a multi-modal approach for hereditary cancer diagnostics.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 21, 2026

Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study.

Journal: Molecular and clinical oncology

Published: December 17, 2024

Generating a database by calculating the pathogenic variants and allele frequencies detected in hereditary cancers using genomic data: A nation study.

Journal: Global medical genetics

Published: November 20, 2024

Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?

Journal: Current oncology (Toronto, Ont.)

Published: November 05, 2023

A Multicenter Study of Genotype Variation/Demographic Patterns in 2475 Individuals Including 1444 Cases With Breast Cancer in Turkey.

Journal: European journal of breast health

Published: March 29, 2023

Prognostic value of pretreatment immune inflammation indices in patients with immune-related tumors.

Journal: Current medical research and opinion

Published: January 11, 2023

Development of a Novel Predictive-Prognostic Scoring Index for Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer.

Journal: Cureus

Published: January 01, 2023

Salvage chemotherapy in patients with nonsmall cell lung cancer after prior immunotherapy: a retrospective, real-life experience study.

Journal: Anti-cancer drugs

Published: August 10, 2022

Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma.

Journal: Clinical laboratory

Published: February 10, 2022

Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience.

Journal: Future oncology (London, England)

Published: November 11, 2021

Male Breast Cancer: Clinical, Demographical, and Pathological Features in a Cohort of 41 Patients.

Journal: Cureus

Published: September 03, 2021

First-line pembrolizumab efficacy in patients with advanced non-small cell lung cancer: A Bi-center retrospective, real-life experience study.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: July 16, 2021